Delivering the Bivalent Covid Booster to the World
When Moderna was faced with swiftly developing a life-saving bivalent COVID booster, they turned to Endpoint’s interactive response technology (IRT) solution. The team’s flexibility, responsiveness, and ingenuity was critical in meeting study demands.
Download your free Case Study from Citeline Clinical’s Scrip Custom Insights, presented in partnership with Endpoint, to discover: